2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Stomatitis
1
Mucositis
1
Interventions
Cyclophosphamide
2068
Radiotherapy
1990
Cisplatin
1857
Carboplatin
1560
Gemcitabine
1455
Paclitaxel
1322
Bevacizumab
1321
pembrolizumab
1240
Docetaxel
1227
Oxaliplatin
1184
Capecitabine
1179
Fluorouracil
1083
Dexamethasone
979
Magnetic Resonance Spectroscopy
973
Nivolumab
936
Rituximab
929
Drug Therapy
915
Surveys and Questionnaires
899
Doxorubicin
845
Etoposide
843
Radiosurgery
816
Blood Specimen Collection
816
Irinotecan
784
Cytarabine
743
fludarabine
726
Leucovorin
684
Surgical Procedures, Operative
641
Lenalidomide
619
Biopsy
595
Specimen Handling
570
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Poloxamer
×
Clear all
NCT01898091
2017-03-06
OM
Medical University of South Carolina
Phase 2
Completed
50 enrolled
9 charts